Get Your Personalized Supplement StackSupplement Stack Quiz

Folate Metafolin

Also known as: Folate, 5-MTHF, Metafolin, Vitamin B9, 5-methyltetrahydrofolate, L-methylfolate calcium, L-methylfolate

Overview

Folate, also known as Vitamin B9, is an essential water-soluble B-vitamin naturally found in leafy greens, legumes, and certain fruits. L-methylfolate (5-MTHF) is the biologically active form of folate, and Metafolin is a branded form of L-methylfolate calcium used in supplements. Unlike folic acid, which requires enzymatic conversion in the body, L-methylfolate is directly bioavailable and can be utilized immediately. This bypasses potential issues in individuals with genetic variations that impair folic acid metabolism. Folate supplementation is primarily used to prevent folate deficiency, significantly reduce the risk of neural tube defects during pregnancy, and support overall cardiovascular and cognitive health. Extensive high-quality research, including numerous randomized controlled trials and meta-analyses, supports its efficacy and safety, particularly in preventing birth defects and contributing to various metabolic processes.

Benefits

Folate supplementation offers several evidence-based benefits. Meta-analyses of randomized controlled trials (RCTs) indicate that folate significantly reduces the risk of all-cause mortality, birth defects (especially neural tube defects by 50-70%), and improves cardiovascular and diabetes-related outcomes. It also shows promise in supporting neurocognitive function. For pregnant women, folate is crucial to prevent neural tube defects, with benefits observed when supplementation begins preconception and continues through early pregnancy. Individuals with folate deficiency or elevated homocysteine levels may experience cardiovascular and cognitive improvements. While some studies suggest folate may reduce the risk of certain pregnancy complications and improve endothelial function, there's also evidence of a potential increased risk for certain cancers (e.g., colorectal adenomatous lesions, prostate cancer) at higher intakes, though the overall benefits at recommended doses generally outweigh these concerns. The time course for benefits varies; birth outcome prevention requires early and consistent intake, while cardiovascular and cognitive benefits may manifest over longer periods.

How it works

Folate, specifically in its active form L-methylfolate, is a crucial participant in one-carbon metabolism. This metabolic pathway is essential for vital cellular processes, including DNA synthesis, repair, and methylation, as well as amino acid metabolism. L-methylfolate acts as a methyl donor in the methionine cycle, which is critical for converting homocysteine to methionine, thereby lowering homocysteine levels—a risk factor for cardiovascular disease. It also supports the synthesis of nucleotides, the building blocks of DNA and RNA, and plays a role in neurotransmitter synthesis in the brain. Metafolin (L-methylfolate) is directly bioavailable, meaning it does not require enzymatic reduction by dihydrofolate reductase, unlike synthetic folic acid. This direct absorption ensures more efficient utilization and allows it to readily cross the blood-brain barrier.

Side effects

Folate supplementation, including Metafolin, is generally considered safe at recommended doses. Mild gastrointestinal discomfort is a rare but possible side effect. Allergic reactions are uncommon, and significant adverse effects at standard doses are not typically reported. However, there are important safety considerations. Folate may interact with certain medications, including anticonvulsants and methotrexate, potentially altering their efficacy or increasing side effects. A critical contraindication is in individuals with undiagnosed Vitamin B12 deficiency; high doses of folate can mask the hematologic symptoms of B12 deficiency, potentially allowing neurological damage to progress undetected. While folate is essential during pregnancy, some research suggests a potential increased risk for certain cancers (e.g., colorectal adenomatous lesions, prostate cancer) with very high folate intake, though this evidence is not definitive and the benefits at recommended doses generally outweigh this theoretical risk. Individuals with MTHFR polymorphisms may benefit more from L-methylfolate than folic acid due to impaired conversion of folic acid to its active form.

Dosage

For the prevention of neural tube defects, a minimum effective dose of 400 mcg/day of folate is recommended, ideally starting preconception and continuing through early pregnancy. Optimal dosage ranges for L-methylfolate in supplements typically fall between 400-800 mcg/day. The maximum safe dose is generally considered to be up to 1 mg/day (1000 mcg/day); higher doses should only be taken under medical supervision. Metafolin, being the active form, offers better bioavailability compared to folic acid, especially for individuals with MTHFR mutations, as it bypasses the need for enzymatic conversion. Timing is crucial for birth defect prevention, requiring consistent intake before and during early pregnancy. For other benefits like cardiovascular or cognitive support, long-term consistent supplementation is often required. It is important to monitor Vitamin B12 levels concurrently, as B12 is a crucial cofactor in folate metabolism.

FAQs

Is Metafolin better than folic acid?

Yes, Metafolin is the bioactive form of folate (L-methylfolate) and is more readily utilized by the body, especially for individuals with MTHFR gene variants who may have difficulty converting folic acid to its active form.

Is it safe during pregnancy?

Yes, L-methylfolate (Metafolin) is safe and highly recommended during pregnancy, particularly starting preconception, to significantly reduce the risk of neural tube defects in the developing fetus.

How long until benefits appear?

For neural tube defect prevention, supplementation must begin before conception and continue through early pregnancy. Other benefits, such as cardiovascular or cognitive improvements, may take weeks to months of consistent supplementation to manifest.

Can it cause cancer?

Some studies suggest a potential link between very high folate intake and an increased risk of certain cancers, but the evidence is not definitive. At recommended doses, the established benefits of folate generally outweigh this theoretical risk.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC7770110/ – This umbrella review and meta-analysis of 108 meta-analyses (median sample size >3,000) found that folate supplementation significantly reduces the risk of all-cause mortality, birth defects, and improves cardiovascular and diabetes-related outcomes. It also noted some potential increased cancer risks, highlighting the need for balanced assessment of benefits and risks.
https://pubmed.ncbi.nlm.nih.gov/38092151/ – This 12-week randomized controlled trial with 60 adults demonstrated that 800 mcg of folic acid supplementation led to increases in plasma 5-MTHF and significant metabolic changes. The study confirms the bioavailability and metabolic impact of folate supplementation, providing insights into its physiological effects.
https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2021.661198/full – This systematic review and meta-analysis investigated the relationship between folate levels and Alzheimer's Disease. It found consistently lower folate levels in Alzheimer's patients compared to controls, suggesting a potential neuroprotective role for folate and supporting its importance for cognitive health.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10900167/ – This study, likely a more detailed report or follow-up to the Khalid et al. (2023) metabolomic RCT, provides further evidence on the metabolic changes induced by folic acid supplementation. It reinforces the understanding of how folate impacts various metabolic pathways in the body.